571 related articles for article (PubMed ID: 17467808)
1. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
Papiol S; Arias B; Gastó C; Gutiérrez B; Catalán R; Fañanás L
J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
[TBL] [Abstract][Full Text] [Related]
2. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
[TBL] [Abstract][Full Text] [Related]
3. HPA axis activation in major depression and response to fluoxetine: a pilot study.
Young EA; Altemus M; Lopez JF; Kocsis JH; Schatzberg AF; DeBattista C; Zubieta JK
Psychoneuroendocrinology; 2004 Oct; 29(9):1198-204. PubMed ID: 15219644
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the glucocorticoid receptor gene and major depression.
van Rossum EF; Binder EB; Majer M; Koper JW; Ising M; Modell S; Salyakina D; Lamberts SW; Holsboer F
Biol Psychiatry; 2006 Apr; 59(8):681-8. PubMed ID: 16580345
[TBL] [Abstract][Full Text] [Related]
5. Association of HPA axis genes with suicidal behaviour in schizophrenia.
De Luca V; Tharmalingam S; Zai C; Potapova N; Strauss J; Vincent J; Kennedy JL
J Psychopharmacol; 2010 May; 24(5):677-82. PubMed ID: 18838498
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
[TBL] [Abstract][Full Text] [Related]
7. Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major depression.
Liu Z; Zhu F; Wang G; Xiao Z; Wang H; Tang J; Wang X; Qiu D; Liu W; Cao Z; Li W
Neurosci Lett; 2006 Sep; 404(3):358-62. PubMed ID: 16815632
[TBL] [Abstract][Full Text] [Related]
8. Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patients.
Haefner S; Baghai TC; Schule C; Eser D; Spraul M; Zill P; Rupprecht R; Bondy B
Neuropsychobiology; 2008; 58(3-4):154-62. PubMed ID: 19088492
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.
Choi MJ; Kang RH; Lim SW; Oh KS; Lee MS
Brain Res; 2006 Nov; 1118(1):176-82. PubMed ID: 16979146
[TBL] [Abstract][Full Text] [Related]
10. The CRHR1 gene: a marker for suicidality in depressed males exposed to low stress.
Wasserman D; Sokolowski M; Rozanov V; Wasserman J
Genes Brain Behav; 2008 Feb; 7(1):14-9. PubMed ID: 17376150
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment.
Binder EB; Salyakina D; Lichtner P; Wochnik GM; Ising M; Pütz B; Papiol S; Seaman S; Lucae S; Kohli MA; Nickel T; Künzel HE; Fuchs B; Majer M; Pfennig A; Kern N; Brunner J; Modell S; Baghai T; Deiml T; Zill P; Bondy B; Rupprecht R; Messer T; Köhnlein O; Dabitz H; Brückl T; Müller N; Pfister H; Lieb R; Mueller JC; Lõhmussaar E; Strom TM; Bettecken T; Meitinger T; Uhr M; Rein T; Holsboer F; Muller-Myhsok B
Nat Genet; 2004 Dec; 36(12):1319-25. PubMed ID: 15565110
[TBL] [Abstract][Full Text] [Related]
12. Relationship of cortisol levels and genetic polymorphisms to antidepressant response to placebo and fluoxetine in patients with major depressive disorder: a prospective study.
Ventura-Juncá R; Symon A; López P; Fiedler JL; Rojas G; Heskia C; Lara P; Marín F; Guajardo V; Araya AV; Sasso J; Herrera L
BMC Psychiatry; 2014 Aug; 14():220. PubMed ID: 25086452
[TBL] [Abstract][Full Text] [Related]
13. Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment.
Zobel AW; Schulze-Rauschenbach S; von Widdern OC; Metten M; Freymann N; Grasmäder K; Pfeiffer U; Schnell S; Wagner M; Maier W
J Psychiatr Res; 2004; 38(4):377-83. PubMed ID: 15203289
[TBL] [Abstract][Full Text] [Related]
14. Stress responsive neurohormones in depression and anxiety.
Ströhle A; Holsboer F
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
[TBL] [Abstract][Full Text] [Related]
15. Evidence of an association between the vasopressin V1b receptor gene (AVPR1B) and childhood-onset mood disorders.
Dempster EL; Burcescu I; Wigg K; Kiss E; Baji I; Gadoros J; Tamás Z; Kennedy JL; Vetró A; Kovacs M; Barr CL
Arch Gen Psychiatry; 2007 Oct; 64(10):1189-95. PubMed ID: 17909131
[TBL] [Abstract][Full Text] [Related]
16. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
Chang HS; Won E; Lee HY; Ham BJ; Lee MS
Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
[TBL] [Abstract][Full Text] [Related]
17. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
[TBL] [Abstract][Full Text] [Related]
18. Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response.
Navinés R; Martín-Santos R; Gómez-Gil E; Martínez de Osaba MJ; Imaz ML; Gastó C
Psychoneuroendocrinology; 2007 May; 32(4):411-6. PubMed ID: 17337123
[TBL] [Abstract][Full Text] [Related]
19. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt DJ; Metspalu A
Eur Neuropsychopharmacol; 2009 Jun; 19(6):451-6. PubMed ID: 19272758
[TBL] [Abstract][Full Text] [Related]
20. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
Ströhle A
Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
